Danny Lafrance

Danny Lafrance is an experienced professional in the biotechnology and pharmaceutical sectors, currently serving as the Director of Process Development and Manufacturing at Morphic Therapeutic. Previously, Danny held the position of Associate Director of CMC Operations at Bacainn Therapeutics and worked as a Principal Scientist in Chemical Development at Kintai Therapeutics. Additional experience includes serving as a Senior Scientist on a contract with Vertex Pharmaceuticals at PPD and a Scientist II role at TetraPhase Pharmaceuticals.